26 abril 2015
New results show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/LGtc-JniTZ8/150425215744.htm
